Cameron Curley

516 total citations
25 papers, 161 citations indexed

About

Cameron Curley is a scholar working on Hematology, Oncology and Genetics. According to data from OpenAlex, Cameron Curley has authored 25 papers receiving a total of 161 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Hematology, 7 papers in Oncology and 5 papers in Genetics. Recurrent topics in Cameron Curley's work include Hematopoietic Stem Cell Transplantation (12 papers), Acute Myeloid Leukemia Research (8 papers) and Acute Lymphoblastic Leukemia research (4 papers). Cameron Curley is often cited by papers focused on Hematopoietic Stem Cell Transplantation (12 papers), Acute Myeloid Leukemia Research (8 papers) and Acute Lymphoblastic Leukemia research (4 papers). Cameron Curley collaborates with scholars based in Australia, New Zealand and United States. Cameron Curley's co-authors include Glen Kennedy, Simon Durrant, Jason Butler, Geoffrey R. Hill, Siok‐Keen Tey, Cheryl Hutchins, Kirk Morris, Stuart D. Olver, Ashish Misra and Antiopi Varelias and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and British Journal of Haematology.

In The Last Decade

Cameron Curley

25 papers receiving 159 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Cameron Curley Australia	8	116	57	41	25	21	25	161
Alexis Melton United States	9	106 0.9×	63 1.1×	17 0.4×	20 0.8×	30 1.4×	19	177
Ramdane Belhocine France	9	183 1.6×	42 0.7×	67 1.6×	37 1.5×	33 1.6×	18	223
K. Douglas United Kingdom	5	177 1.5×	31 0.5×	44 1.1×	30 1.2×	24 1.1×	7	194
D H Fowler United States	5	204 1.8×	191 3.4×	39 1.0×	28 1.1×	14 0.7×	7	300
Luděk Pour Czechia	8	61 0.5×	51 0.9×	69 1.7×	25 1.0×	7 0.3×	88	206
Eva Wagner-Drouet Germany	8	92 0.8×	47 0.8×	81 2.0×	13 0.5×	20 1.0×	28	175
Yoshitoshi Ohtsuka Japan	9	138 1.2×	25 0.4×	38 0.9×	62 2.5×	33 1.6×	20	208
Ghada Abusin United States	7	56 0.5×	32 0.6×	14 0.3×	30 1.2×	16 0.8×	15	119
Lars‐Olof Mügge Germany	8	182 1.6×	26 0.5×	62 1.5×	45 1.8×	41 2.0×	21	224
John H. Fargo United States	7	67 0.6×	21 0.4×	31 0.8×	9 0.4×	9 0.4×	13	247

Countries citing papers authored by Cameron Curley

Since Specialization

Citations

This map shows the geographic impact of Cameron Curley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cameron Curley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cameron Curley more than expected).

Fields of papers citing papers by Cameron Curley

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cameron Curley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cameron Curley. The network helps show where Cameron Curley may publish in the future.

Co-authorship network of co-authors of Cameron Curley

This figure shows the co-authorship network connecting the top 25 collaborators of Cameron Curley. A scholar is included among the top collaborators of Cameron Curley based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cameron Curley. Cameron Curley is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Boots, Robert, Cameron Curley, Nicole Gavin, et al.. (2024). Virtual reality experience in haemato-oncology patients—technical evaluation (ViREB-TE). SHILAP Revista de lepidopterología. 2(1). 1 indexed citations

Brown, Teresa, et al.. (2022). Malnutrition and clinical outcomes post alloSCT. Journal of Human Nutrition and Dietetics. 36(4). 1253–1260. 1 indexed citations

Kliman, David, Glen Kennedy, Cameron Curley, et al.. (2022). The improvement in overall survival from unrelated donor transplantation in Australia and New Zealand is driven by a reduction in non-relapse mortality: A study from the ABMTRR. Bone Marrow Transplantation. 57(6). 982–989. 3 indexed citations

Curley, Cameron, Siok‐Keen Tey, Jason Butler, et al.. (2022). Real-World Outcomes with CD19 CAR T-Cell Therapy for B-Cell Malignancies in Regional/Rural Australia: Results from the Queensland CAR T-Cell Program. Blood. 140(Supplement 1). 7500–7501. 1 indexed citations

Kennedy, Glen, Siok‐Keen Tey, Luke Buizen, et al.. (2021). A phase 3 double-blind study of the addition of tocilizumab vs placebo to cyclosporin/methotrexate GVHD prophylaxis. Blood. 137(14). 1970–1979. 32 indexed citations

Butler, Jason, et al.. (2020). “Real World” Australian Experience of Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) in Adults with Severe Aplastic Anaemia.. 4(4). 1–16. 1 indexed citations

Ritchie, David, Glen Kennedy, Sam Milliken, et al.. (2020). Allogeneic Stem Cell Transplantation for Mantle Cell Lymphoma Can Achieve Durable Remission and Myeloablative Conditioning Is Associated with Inferior Survival: An Australasian Bone Marrow Transplant Recipient Registry Study. Blood. 136(Supplement 1). 7–8. 1 indexed citations

Henden, Andrea, Antiopi Varelias, Judy Avery, et al.. (2019). Pegylated interferon-2α invokes graft-versus-leukemia effects in patients relapsing after allogeneic stem cell transplantation. Blood Advances. 3(20). 3013–3019. 14 indexed citations

Zhang, Ping, et al.. (2019). Effect of plasmapheresis on ATG (Thymoglobulin) clearance prior to adoptive T cell transfer. Bone Marrow Transplantation. 54(12). 2110–2116. 11 indexed citations

10.

Kennedy, Glen, Siok‐Keen Tey, Cameron Curley, et al.. (2019). Results of a Phase III Double-Blind Study of the Addition of Tocilizumab Vs. Placebo to Cyclosporin/Methotrexate Gvhd Prophylaxis after HLA-Matched Allogeneic Stem Cell Transplantation. Blood. 134(Supplement_1). 368–368. 6 indexed citations

11.

Morris, Kirk, et al.. (2017). Use of brentuximab vedotin as salvage therapy pre‐allogeneic stem cell transplantation in relapsed/refractory CD30 positive lympho‐proliferative disorders: a single centre experience. Internal Medicine Journal. 47(5). 574–578. 7 indexed citations

12.

Tey, Siok‐Keen, Slavica Vučković, Antiopi Varelias, et al.. (2016). Pharmacokinetics and immunological outcomes of alemtuzumab-based treatment for steroid-refractory acute GvHD. Bone Marrow Transplantation. 51(8). 1153–1155. 3 indexed citations

13.

Barras, Michael, et al.. (2016). A randomized trial of olanzapine versus palonosetron versus infused ondansetron for the treatment of breakthrough chemotherapy-induced nausea and vomiting in patients undergoing hematopoietic stem cell transplantation. Supportive Care in Cancer. 25(2). 607–613. 14 indexed citations

14.

Baidya, Shoma, et al.. (2014). Platelet Transfusion Refractoriness Pre-Allograft Is Associated with Higher Rates of Platelet Non-Engraftment and Graft Failure in Adult Allogeneic Haematopoietic Stem Cell Transplantation for Haematological Malignancies. Blood. 124(21). 1143–1143. 1 indexed citations

15.

Bajel, Ashish, Cameron Curley, Andrew Lim, et al.. (2014). Allogeneic Stem Cell Transplantation (allo-SCT) for Chronic Myelomonocytic Leukemia – a Multicentre Australian Experience: Prognostic Factors for Survival and Relapse. Blood. 124(21). 1927–1927. 1 indexed citations

16.

Curley, Cameron, Geoffrey R. Hill, Angela R. McLean, & Glen Kennedy. (2013). Immunotherapy following relapse of acute leukaemia after T‐cell‐replete allogeneic peripheral blood progenitor cell transplantation: importance of new onset chronic graft‐versus‐host disease. International Journal of Laboratory Hematology. 36(2). 197–204. 4 indexed citations

17.

Kennedy, Glen, Antiopi Varelias, Slavica Vučković, et al.. (2013). The Addition Of Interleukin-6 Inhibition To Standard Gvhd Prophylaxis Prevents Acute Gvhd: Interim Results Of a Phase I/II Clinical Study. Blood. 122(21). 908–908. 4 indexed citations

18.

Burge, Matthew, Mohammed F. Islam, Kirk Morris, et al.. (2012). Successful treatment of a primary mediastinal germ cell tumour complicated by hemophagocytic syndrome. Asia-Pacific Journal of Clinical Oncology. 8(4). e97–8. 1 indexed citations

19.

Curley, Cameron, et al.. (2011). Outcomes after major or bidirectional ABO‐mismatched allogeneic hematopoietic progenitor cell transplantation after pretransplant isoagglutinin reduction with donor‐type secretor plasma with or without plasma exchange. Transfusion. 52(2). 291–297. 26 indexed citations

20.

Curley, Cameron, et al.. (2010). Acute myeloid leukemia, the 3q21q26 syndrome and diabetes insipidus: A case presentation. Asia-Pacific Journal of Clinical Oncology. 6(2). 77–79. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact